2. A common disease in Pakistan and other developing countries
Its prevalence is estimated to be 175 per 100,000 of population
40% of Pakistanis harbour tb bacilli
Diagnosis of abdominal TB is usually very difficult, due to nonspecific symptoms and signs.
Diagnostic confirmation often requires histopathological examination of the surgical specimen
TB can be seen in any age group that is Immunocomprimised
-WHO
Epidemiology:
Both gender: equally affected
Most common age: 35-45 years
[Sanai, et al. Aliment Pharmacol Ther 2005;22:685-700]
Introduction
3. Mode of infection
Swallowing of
infected sputum
Hematogenous spread
from pulmonary focus
Ingestion of contaminated
milk products
Direct spread from
adjacent organs
Pathogenesis of Abdominal TB
4. 1)Bacilli in depth of mucosal glands
2) Phagocytes carry bacilli to Peyers patches
3) Formation of Tubercles, which undergo necrosis
4) Ulcer Formation
5) Accumulation of collagen, with thickening and stenosis
6) Inflammation in Submucosa that reaches the serosa
7) Bacilli reach lymphatics
A) Lymphatic obstruction of bowel
-----Thick fixed mass
B) Regional lymph nodes
-Hyperplasia
-Caseation necrosis
-Calcification
PATHOLOGYPATHOLOGY
5. 1. By ingestion
Ingestion of food contaminated with tubercle bacilli
causing Primary Intestinal Tuberculosis
Ingestion of sputum containing tuberculous
bacteria from primary pulmonary focus -
Secondary Intestinal Tuberculosis
1. Hematogenous spread from lungs
2. Through lymphatics (neck)
3. Fallopian tubes (retrograde spread)
Mode Of Spread
6. Intestinal tubercu
Ileocaecal
region
Small bowel
& colon
Niall O, et al. World J Surg 1997;21:492-499
Constitutes 70-78% cases of
abdominal
tuberculosis
Most common site of gastrointestinal
tuberculosis is ileocaecal region
Stasis
Abundant peyer’s patches
Alkaline media
Bacterial contact time is more
Minimal digestive activity
Maximum absorption in the area
7. Intestinal tuberculosis
Ulcerative type
Formation of mucosal ulcers
• Bleeding
• Perforation
• Fistulation
• Stricture
Hyperplastic type
Extensive inflammatory changes
• Obstruction
• Mass
Aston NO. World J Surg 1997;21:492-499
12. Concomitant PTB
Concomitant PTB
Present in 15-25% only
Sputum smear and culture
for AFB:
Low diagnostic yield
Abnormal CXR:
19-83%
Average = 38%Marshall JB, et al. Am J Gastroenterol 1993;88:989-999
Horvath KD, et al. Am J Gastroenterol 1998;93:692-696
Faylona JM, et al. Ann Coll Surg 1993;3:65-70
13. Blood tests
No specific diagnostic blood tests available
Common blood parameters:
Elevated ESR
Almost always raised but not exceed 60 mm/hr
[Manohar, et al. Gut 1990;31:1130-2]
Mild anemia
normochromic/ normocytic
[Marshall JB, et al. Am J Gastroenterol 1993;88:989-999]
Mild leukocytosis
[Manohar, et al. Gut 1990;31:1130-2]
14. Tuberculin test
Huebner, et al. Clin Infect Dis 1993; 17:968-75
IGRA:
The test involves incubating the patient’s blood with synthetic
proteins which represent M. tuberculosis proteins; interferon
gamma released by sensitized leucocytes is measured.
15. GeneXpert TB Test
The Genexpert test is a new molecular test for TB. The test is
a molecular test which detects the DNA in TB bacteria. It uses
a sputum sample and can give a result in less than 2 hours. It
can also detect the genetic mutations associated with
resistance to the drug Rifampicin.
19. Endoscopy and biopsy
• Evaluation of diseased area
• Histopathology: granulomas, caseation
necrosis, staining for AFB
• Culture for M. tuberculosis
• PCR for M. tuberculosis: 100% sensitivity
Uzunkoy, et al. World J Gastroenterol 2004;10(24):3647-3549
Tzoanopoulos, et al. Eur J Intern Med 2003;14:367-371
23. Medical management:
First line drugs:
INH
Rifampicin
Pyrazinamide
Ethambutol
Second line drugs:
Amikacin, kanamycin, Ciprofloxacin,
Clarithrymycin, Azythromycin, Rifabutin
Treatment to be continued for 6-9 months depending
on the prevalence of drug resistant TB.
Treatment Weight=50kg
Isoniazid
100 mg 3
OD
Rifampicin 450 mg OD
Ethambutol
400 mg 3
OD
Pyrazinamide
500mg 3
OD
DRUG STRENGTH
Isoniazid Tab 100 mg
Rifampicin Tab 300/450/600mg
Ethambutol Tab 400mg
Pyrazinamide Tab 500mg
MYRIN P
I 75+
R150+E275+PZA400
(>71 kg 5 tab/day, 55-70 kg 4
tab/day, 40-54 kg 3 tab/day)
MYRIN I75+R150+E300
24. There is no difference in efficacy of anti-tuberculosis
therapy delivered for either 6 months or 9 months in
either gastrointestinal or peritoneal tuberculosis.
Clin Infect Dis. 2015 Sep 1;61(5):750-7. doi: 10.1093/cid/civ376. Epub 2015 May 12
Role of Corticosteroids:
Used to decrease fibrosis during healing so as to prevent development
of obstruction, but may delay healing and predispose to perforation or
further obstruction
Current studies show that even obstructing intestinal lesions can be
successfully treated with ATT, so use of steroids is declining these
days
25. With the advent of antituberculous therapy, surgery is usually reserved for
those cases where it is absolutely indicated as in cases of non-resolving
intestinal obstruction, perforation and abscess or fistula formation.
Surgical Management:
1. Ileocaecal resection with 5 cm margin
2. Stricturoplasty- single stricture
3. Single strictutre with friable bowel : Resection
4. Multiple Strictures: Resection and anastomosis
5. Multiple strictures with long segment gaps: Multiple stricturiplasty
6. Early perforation: resection and anastomosis (due to friable bowels)
7. Perforation with severe contamination: resection with colostomy
8. Adhesiolysis by laproscopy (Very difficult procedure)
9. Drainage of abscesses and treatment for fistula in ano
26. THANK YOU!!
References:
1) SRB MANUAL OF SURGERY
2) Textbook of Clinical Gastroenterology and
Hepatology
THE DPG WAY….ALL
THE WAY!!
Editor's Notes
Intestinal (Koenig’s syndrome)
Iliocaecal region
Ulcerative -60%
Hyperplastic-10%
Mixed-30%
Ileal region
Stricture type
Peritoneal tuberculosis
Acute
Chronic
Ascitic
Encysted
Plastic
Purulent
Common site: Ileocecal, stasis, alkaline media, bacterial contact time is more, decreased digestive activity, max absorption in the area
Patients appear sick and emaciated. A low grade temperature
is noted. Peripheral lymphadenopathy should be carefully
sought as it provides an easy source of diagnosis. Diseased
nodes frequently fuse together (“matted”) and form adhesions
with the surrounding tissues. On examination, the nodes
appear “fixed” and sinus tracks may form through the overlying
skin. A palpable mass in the right iliac fossa is typical, but
masses may be felt at other sites including the epigastrium
(rolled-up omentum). Visible peristalsis is noted in subacute
bowel obstruction. Tenderness is localized to the site of disease.
Diffuse tenderness with a “doughy” feel is suggestive of peritoneal
involvement. Presence of an uneven abdominal distention
indicates loculated ascites. Fecal fistulae, and perianal
fistulae and fissures may be noted. Enlargement of liver and
spleen indicates involvement of these organs.
http://depositfiles.com/files/f0s5tnusx
QuantiFERON®-TB Gold In-Tube test (QFT-GIT);
T-SPOT®.TB test
Differentiate between Active TB and Latent TB
IL TB: Absent ascending colon and caecum with dilation of terminal ileum
denosine deaminase (ADA) is a protein that is produced by cells throughout the body and is associated with the activation of lymphocytes, a type of white blood cell that plays a role in the immune response to infections. Conditions that trigger theimmune system, such as an infection by Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), may cause increased amounts of ADA to be produced in the areas where the bacteria are present. This test measures the amount of adenosine deaminase present in pleural fluid in order to help diagnose a tuberculosis infection of the pleurae.
surgical enlargement of the caliber of a constrictedbowel segment by means of longitudinal incision and transverse suturing of the stricture.